Biomarkers of microbiome disruption for patient stratification in clinical trials of microbiome therapeutics in IBD

Time: 4:30 pm
day: Conference Day One

Details:

  • Microbiome heterogeneity in structural, functional, and immuno-modulatory properties in IBD
  • Baseline biomarkers predictive of microbiome therapeutic pharmacodynamics in IBD
  • Relating microbiome disruption and immuno-modulatory properties to inform patient stratification

Speakers: